Janney Montgomery Scott
CLVS

Janney Montgomery Scott’s Clovis Oncology, Inc. CLVS Stock Holding History

Janney Montgomery Scott’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,000
Closed -$49K – 2453
2021
Q3 		$49K Hold
11,000
– – ﹤0.01% 2276
2021
Q2 		$64K Buy
+11,000
New +$64.4K ﹤0.01% 2227
2020
Q1 		– Sell
-23,550
Closed -$246K – 2137
2019
Q4 		$246K Sell
23,550
-40,662
-63% -$296K ﹤0.01% 1811
2019
Q3 		$252K Buy
+64,212
New +$519K ﹤0.01% 1778
2017
Q4 		– Sell
-7,745
Closed -$638K – 1987
2017
Q3 		$638K Buy
+7,745
New +$614K 0.01% 1133

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janney Montgomery Scott's CLVS Position: Q4 2021 in Review

Janney Montgomery Scott sold out of Clovis Oncology, Inc. (CLVS) in Q4 2021, closing a stake of 11,000 shares — an estimated $49K sold.

Janney Montgomery Scott first reported a position in CLVS in Q3 2017 and held it in 5 quarters. The position peaked at $638K in Q3 2017. 153 funds tracked by Wall St. Rank hold CLVS as of Q4 2021.

  • Janney Montgomery Scott reported no remaining Clovis Oncology, Inc. position as of Q4 2021 after selling out during the quarter.
  • Janney Montgomery Scott sold 11,000 Clovis Oncology, Inc. shares in Q4 2021, an estimated $49K.
  • Janney Montgomery Scott first reported a position in Clovis Oncology, Inc. in Q3 2017 and held it in 5 quarters.
  • Janney Montgomery Scott's Clovis Oncology, Inc. position peaked at $638K in Q3 2017.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2021.

Based on Janney Montgomery Scott's 13F filing for Q4 2021, filed 27 Jan 2022.